Consolidation therapy in patients with advanced ovarian cancer.
Consolidation chemotherapy, to avoid relapses in Stage III or IV ovarian carcinoma is a major challenge in the management of ovarian carcinoma. The Author discusses, through a critical view of the more recent literature, the different approach to the problem. In particular he tries to answer the two principal questions regarding ovarian tumors: how to increase the number of patients with optimal response; how to consolidate the patients who achieve such a response.